1743 related articles for article (PubMed ID: 28359749)
1. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.
Andrieu S; Guyonnet S; Coley N; Cantet C; Bonnefoy M; Bordes S; Bories L; Cufi MN; Dantoine T; Dartigues JF; Desclaux F; Gabelle A; Gasnier Y; Pesce A; Sudres K; Touchon J; Robert P; Rouaud O; Legrand P; Payoux P; Caubere JP; Weiner M; Carrié I; Ousset PJ; Vellas B;
Lancet Neurol; 2017 May; 16(5):377-389. PubMed ID: 28359749
[TBL] [Abstract][Full Text] [Related]
2. Effect of Long-Term Omega 3 Polyunsaturated Fatty Acid Supplementation with or without Multidomain Lifestyle Intervention on Muscle Strength in Older Adults: Secondary Analysis of the Multidomain Alzheimer Preventive Trial (MAPT).
Rolland Y; Barreto PS; Maltais M; Guyonnet S; Cantet C; Andrieu S; Vellas B
Nutrients; 2019 Aug; 11(8):. PubMed ID: 31426362
[TBL] [Abstract][Full Text] [Related]
3. Effects of multidomain lifestyle intervention, omega-3 supplementation or their combination on physical activity levels in older adults: secondary analysis of the Multidomain Alzheimer Preventive Trial (MAPT) randomised controlled trial.
Barreto PS; Rolland Y; Cesari M; Dupuy C; Andrieu S; Vellas B;
Age Ageing; 2018 Mar; 47(2):281-288. PubMed ID: 29136094
[TBL] [Abstract][Full Text] [Related]
4. Effect of Multidomain Intervention, Omega-3 Polyunsaturated Fatty Acids Supplementation or their Combinaison on Cognitive Function in Non-Demented Older Adults According to Frail Status: Results from the MAPT Study.
Tabue-Teguo M; Barreto de Souza P; Cantet C; Andrieu S; Simo N; Fougère B; Dartigues JF; Vellas B
J Nutr Health Aging; 2018; 22(8):923-927. PubMed ID: 30272094
[TBL] [Abstract][Full Text] [Related]
5. Effect of long-term omega-3 supplementation and a lifestyle multidomain intervention on intrinsic capacity among community-dwelling older adults: Secondary analysis of a randomized, placebo-controlled trial (MAPT study).
Giudici KV; de Souto Barreto P; Beard J; Cantet C; Araujo de Carvalho I; Rolland Y; Vellas B;
Maturitas; 2020 Nov; 141():39-45. PubMed ID: 33036701
[TBL] [Abstract][Full Text] [Related]
6. Plasma p-tau181 as an outcome and predictor of multidomain intervention effects: a secondary analysis of a randomised, controlled, dementia prevention trial.
Coley N; Zetterberg H; Cantet C; Guyonnet S; Ashton NJ; Vellas B; Blennow K; Andrieu S;
Lancet Healthy Longev; 2024 Feb; 5(2):e120-e130. PubMed ID: 38310892
[TBL] [Abstract][Full Text] [Related]
7. Association of 3-Year Multidomain Intervention and Omega-3 Supplementation with Frailty Incidence.
Guerville F; de Souto Barreto P; Giudici KV; Rolland Y; Vellas B;
J Am Geriatr Soc; 2019 Aug; 67(8):1700-1706. PubMed ID: 31169912
[TBL] [Abstract][Full Text] [Related]
8. MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER'S DISEASE: DESIGN AND BASELINE DATA.
Vellas B; Carrie I; Gillette-Guyonnet S; Touchon J; Dantoine T; Dartigues JF; Cuffi MN; Bordes S; Gasnier Y; Robert P; Bories L; Rouaud O; Desclaux F; Sudres K; Bonnefoy M; Pesce A; Dufouil C; Lehericy S; Chupin M; Mangin JF; Payoux P; Adel D; Legrand P; Catheline D; Kanony C; Zaim M; Molinier L; Costa N; Delrieu J; Voisin T; Faisant C; Lala F; Nourhashémi F; Rolland Y; Van Kan GA; Dupuy C; Cantet C; Cestac P; Belleville S; Willis S; Cesari M; Weiner MW; Soto ME; Ousset PJ; Andrieu S
J Prev Alzheimers Dis; 2014 Jun; 1(1):13-22. PubMed ID: 26594639
[TBL] [Abstract][Full Text] [Related]
9. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial.
Ngandu T; Lehtisalo J; Solomon A; Levälahti E; Ahtiluoto S; Antikainen R; Bäckman L; Hänninen T; Jula A; Laatikainen T; Lindström J; Mangialasche F; Paajanen T; Pajala S; Peltonen M; Rauramaa R; Stigsdotter-Neely A; Strandberg T; Tuomilehto J; Soininen H; Kivipelto M
Lancet; 2015 Jun; 385(9984):2255-63. PubMed ID: 25771249
[TBL] [Abstract][Full Text] [Related]
10. Effects of a Six-Month Multi-Ingredient Nutrition Supplement Intervention of Omega-3 Polyunsaturated Fatty Acids, vitamin D, Resveratrol, and Whey Protein on Cognitive Function in Older Adults: A Randomised, Double-Blind, Controlled Trial.
Moran C; Scotto di Palumbo A; Bramham J; Moran A; Rooney B; De Vito G; Egan B
J Prev Alzheimers Dis; 2018; 5(3):175-183. PubMed ID: 29972210
[TBL] [Abstract][Full Text] [Related]
11. Cognitive Changes with Omega-3 Polyunsaturated Fatty Acids in Non-Demented Older Adults with Low Omega-3 Index.
Hooper C; De Souto Barreto P; Coley N; Cantet C; Cesari M; Andrieu S; Vellas B
J Nutr Health Aging; 2017; 21(9):988-993. PubMed ID: 29083439
[TBL] [Abstract][Full Text] [Related]
12. Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease.
Gillette-Guyonnet S; Andrieu S; Dantoine T; Dartigues JF; Touchon J; Vellas B;
Alzheimers Dement; 2009 Mar; 5(2):114-21. PubMed ID: 19328438
[TBL] [Abstract][Full Text] [Related]
13. Multidomain intervention and/or omega-3 in nondemented elderly subjects according to amyloid status.
Delrieu J; Payoux P; Carrié I; Cantet C; Weiner M; Vellas B; Andrieu S
Alzheimers Dement; 2019 Nov; 15(11):1392-1401. PubMed ID: 31558366
[TBL] [Abstract][Full Text] [Related]
14. Defining the Optimal Target Population for Trials of Polyunsaturated Fatty Acid Supplementation Using the Erythrocyte Omega-3 Index: A Step Towards Personalized Prevention of Cognitive Decline?
Coley N; Raman R; Donohue MC; Aisen PS; Vellas B; Andrieu S
J Nutr Health Aging; 2018; 22(8):982-998. PubMed ID: 30272103
[TBL] [Abstract][Full Text] [Related]
15. Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial.
Cukierman-Yaffe T; Bosch J; Diaz R; Dyal L; Hancu N; Hildebrandt P; Lanas F; Lewis BS; Marre M; Yale JF; Yusuf S; Gerstein HC;
Lancet Diabetes Endocrinol; 2014 Jul; 2(7):562-72. PubMed ID: 24898834
[TBL] [Abstract][Full Text] [Related]
16. Omega 3 fatty acid for the prevention of cognitive decline and dementia.
Sydenham E; Dangour AD; Lim WS
Cochrane Database Syst Rev; 2012 Jun; (6):CD005379. PubMed ID: 22696350
[TBL] [Abstract][Full Text] [Related]
17. Effects of a 3-Year Multi-Domain Intervention with or without Omega-3 Supplementation on Cognitive Functions in Older Subjects with Increased CAIDE Dementia Scores.
Chhetri JK; de Souto Barreto P; Cantet C; Pothier K; Cesari M; Andrieu S; Coley N; Vellas B
J Alzheimers Dis; 2018; 64(1):71-78. PubMed ID: 29865075
[TBL] [Abstract][Full Text] [Related]
18. Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trial.
Delrieu J; Vellas B; Guyonnet S; Cantet C; Ovod V; Li Y; Bollinger J; Bateman R; Andrieu S;
Alzheimers Res Ther; 2023 Oct; 15(1):183. PubMed ID: 37872582
[TBL] [Abstract][Full Text] [Related]
19. Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial.
Dangour AD; Allen E; Elbourne D; Fasey N; Fletcher AE; Hardy P; Holder GE; Knight R; Letley L; Richards M; Uauy R
Am J Clin Nutr; 2010 Jun; 91(6):1725-32. PubMed ID: 20410089
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
